ALKERMES | ALKS - PE Price to Earnings


ALKERMES reported $14.9 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie USD 24.03 86.23 Dec/2025
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
ALKERMES USD 14.9 1.11 Sep/2025
Amgen USD 25.31 15.82 Dec/2025
Biogen USD 14.02 4.63 Dec/2025
BioMarin Pharmaceutical USD 19.45 4.32 Sep/2025
Bristol-Myers Squibb USD 9.28 1.04 Dec/2025
Eli Lilly USD 40.21 9.66 Dec/2025
Gilead Sciences USD 15.63 0.08 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
J&J USD 23.62 0.86 Dec/2025
Malin Corporation EUR 11.81 0.72 Jun/2023
Merck USD 13.92 5.08 Dec/2025
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Otsuka Holdings JPY 12.07 3.16 Dec/2025
Ovoca Bio EUR 1.83 3.29 Jun/2024
Pfizer USD 14.48 5.18 Dec/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025